Hashimoto Y, Koue T, Otsuki Y, Yasuhara M, Hori R, Inui K
Department of Pharmacy, Kyoto University, Japan.
J Pharmacokinet Biopharm. 1995 Apr;23(2):205-16. doi: 10.1007/BF02354272.
A simulation study was conducted to compare the cost and performance of various models for population analysis of the steady state pharmacokinetic data arising from a one-compartment model with Michaelis-Menten elimination. The usual Michaelis-Menten model (MM) and its variants provide no estimate of the volume of distribution, and generally give poor estimates of the maximal elimination rate and the Michaelis-Menten constant. The exact solution to the Michaelis-Menten differential equation (TRUE) requires a precise analysis method designed for estimation of population pharmacokinetic parameters (the first-order conditional estimation method) and also considerable computational time to estimate population mean parameters accurately. The one-compartment model with dose-dependent clearance (DDCL), in conjunction with the first-order conditional estimation or Laplacian method, ran approximately 20-fold faster than TRUE and gave accurate population mean parameters for a drug having a long biological half-life relative to the dosing interval. These findings suggest that the well-known MM and its variants should be used carefully for the analysis of blood concentrations of a drug with Michaelis-Menten elimination kinetics, and that TRUE, in conjunction with a precise analysis method, should be considered for estimating population pharmacokinetic parameters. In addition, DDCL is a promising alternative to TRUE with respect to computation time, when the dosing interval is short relative to the biological half-life of a drug.
进行了一项模拟研究,以比较各种模型在分析具有米氏消除的一室模型产生的稳态药代动力学数据时的成本和性能。通常的米氏模型(MM)及其变体无法估计分布容积,并且通常对最大消除率和米氏常数的估计较差。米氏微分方程的精确解(TRUE)需要一种专为估计群体药代动力学参数设计的精确分析方法(一阶条件估计法),并且还需要相当长的计算时间来准确估计群体平均参数。具有剂量依赖性清除率的一室模型(DDCL),结合一阶条件估计或拉普拉斯方法,运行速度比TRUE快约20倍,并且对于相对于给药间隔具有长生物半衰期的药物,能够给出准确的群体平均参数。这些发现表明,对于具有米氏消除动力学的药物血药浓度分析,应谨慎使用著名的MM及其变体,并且在估计群体药代动力学参数时,应考虑将TRUE与精确分析方法结合使用。此外,当给药间隔相对于药物的生物半衰期较短时,就计算时间而言,DDCL是TRUE的一个有前途的替代方法。